ADVFN - Advanced Financial Network.
HOME» NYSE » B » BSX Stock Price » BSX Stock News

Boston Scientific Share News

 Boston Scientific Corp. Stock Price
BSX Stock Price
 Boston Scientific Corp. Stock Chart
BSX Stock Chart
 Boston Scientific Corp. Stock News
BSX Stock News
 Boston Scientific Corp. Company Information
BSX Company Information
 Boston Scientific Corp. Stock Trades
BSX Stock Trades

WSJ BLOG/Health: A.M. Vitals: Data For J&J's Zytiga Supports Wider Use

(This story has been posted on The Wall Street Journal Online's Health Blog at By Mark Long Here's what's making health news this morning: J&J Study May Support Wider Use of Cancer Drug (WSJ): A clinical trial of Johnson & Johnson's new drug Zytiga, already approved for late-stage prostate-cancer patients who have previously used chemotherapy, finds the drug also improved survival in men who hadn't undergone chemo. White House Works to Shape Debate Over Health Law (New York Times): The White House is seizing on an upcoming Supreme Court case on the constitutionality of President Obama's health-care overhaul law to attempt to drum up public support for the benefits provided by the law. Women Who Drink Moderately Have Lower Stroke Risk (NPR's Shots blog): A study published in Stroke suggests that women who drink one serving of alcohol per day had lower stroke rates than their non-drinking counterparts, possibly, in part, by reducing blood clots. FDA Rejects AstraZeneca Move On Generic Seroquel Labeling (Dow Jones Newswires): The FDA has rejected a Citizen Petition from the drug company to hold off approving generic versions of the antipsychotic unless they carried the same label warnings as are currently on the brand-name. Boston Scientific to Buy Cameron Health (WSJ): The device maker said it will pay $150 million up front for closely held Cameron, with additional payments possible hinging on FDA approval and meeting sales goals for Cameron's subcutaneous implantable defibrillator. LSD Helps to Treat Alcoholism (Nature News): A review of previously published research that appears in the Journal of Psychopharmacology suggests the hallucinogen provides benefits lasting three to six months. Forget The Robots: Venture Capitalists Change Their Health Care Investments (KQED/NPR/Kaiser Health News): Investors are turning from biotech and medical devices and are instead looking at companies that help providers, patients and payers address changes brought by the health-care overhaul law. Stem Cells Beat Kidney Rejection (BBC): An eight-patient study published in Science Translational Medicine reports that most of the stem-cell recipients didn't need to take drugs to prevent the organ's rejection by the body. Image source: iStockphoto -For continuously updated news from The Wall Street Journal, see at

Stock News for Boston Scientific (BSX)
10/05/201516:11:28Statement of Changes in Beneficial Ownership (4)
10/05/201516:06:37Current Report Filing (8-k)
10/05/201506:30:00Boston Scientific Receives FDA Approval For SYNERGY™ Bioabsorbable P...
10/02/201516:24:35Statement of Changes in Beneficial Ownership (4)
10/02/201516:24:35Statement of Changes in Beneficial Ownership (4)
10/02/201516:24:35Statement of Changes in Beneficial Ownership (4)
10/02/201516:23:21Statement of Changes in Beneficial Ownership (4)
10/01/201508:30:00Boston Scientific To Webcast Third Quarter 2015 Earnings Call...
09/29/201509:00:00Boston Scientific Launches The Captivator™ EMR Device To Treat D...
09/28/201507:00:00New Survey Reveals True Impact of Severe Asthma on People's Lives
09/28/201506:00:00Eluvia™ Drug-eluting Vascular Stent System Demonstrates 12-month P...
09/22/201508:45:00Technical Data on Healthcare Stocks - Infinity Pharmaceuticals...
09/18/201508:30:00Medical Appliances and Equipment Stocks Technical Report -- Boston...
09/10/201509:00:00Boston Scientific Announces CE Mark for the Vercise™ Primary C...
09/02/201508:30:00Boston Scientific To Participate In 2015 Morgan Stanley Global...
08/26/201508:30:00Boston Scientific To Participate In The 2015 Wells Fargo Healthcare...
08/24/201516:30:00Boston Scientific Announces CE Mark For MRI Compatible Labeling...
08/24/201516:07:02Statement of Changes in Beneficial Ownership (4)
08/20/201516:07:16Statement of Changes in Beneficial Ownership (4)
08/19/201516:45:00Boston Scientific Announces FDA Approval of Innova™ Vascular S...

Boston Scientific and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations